Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harvard Bioscience

0.3825
+0.00561.49%
Post-market: 0.38250.00000.00%19:56 EDT
Volume:288.55K
Turnover:108.69K
Market Cap:16.86M
PE:-1.34
High:0.3995
Open:0.3950
Low:0.3652
Close:0.3769
Loading ...
Jan 25, 2022

Major Issues Report

8-K - Current report
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 23, 2021

Major Issues Report

8-K - Current report
May 19, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 19, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 17, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]